Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Schenk

Showing results (121-130 of 156) with videos related to

Pageof 16
Sort By:
Annals of Hematology|April 30, 2013
Improved tolerability by a modified intermittent treatment schedule of dasatinib for patients with chronic myeloid leukemia resistant or intolerant to imatinibPaul La Rosée, Philippe Martiat, Armin Leitner, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 18, 2020
The Progressive Supranuclear Palsy Clinical Deficits ScaleInes Piot, Kerstin Schweyer, Gesine Respondek, et al.
Journal of Parkinson'S Disease|August 9, 2021
A Multisensory Deficit in the Perception of Pleasantness in Parkinson's DiseaseKathrin S Utz, Max Martini, Anne Mrochen, et al.
Haematologica|December 8, 2010
Dynamics of mutant BCR-ABL-positive clones after cessation of tyrosine kinase inhibitor therapyBenjamin Hanfstein, Martin C Müller, Sebastian Kreil, et al.
Plos One|November 28, 2013
Visual search as a tool for a quick and reliable assessment of cognitive functions in patients with multiple sclerosisKathrin S Utz, Thomas M A Hankeln, Lena Jung, et al.
Haematologica|January 29, 2008
Dynamics of BCR-ABL mutated clones prior to hematologic or cytogenetic resistance to imatinibThomas Ernst, Philipp Erben, Martin C Müller, et al.
Endocrine|March 1, 2017
Presence of headache and headache types in patients with tumors of the sellar region-can surgery solve the problem? Results of a prospective single center studySonja Siegel, Renata Weber Carneiro, Michael Buchfelder, et al.
BMC Cardiovascular Disorders|May 27, 2017
Cryoballoon vs. open irrigated radiofrequency ablation for paroxysmal atrial fibrillation: long-term FreezeAF outcomesArmin Luik, Kevin Kunzmann, Patrick Hörmann, et al.
Therapeutic Advances in Neurological Disorders|November 6, 2014
Patient preferences for disease-modifying drugs in multiple sclerosis therapy: a choice-based conjoint analysisKathrin S Utz, Jana Hoog, Andreas Wentrup, et al.
Plos One|July 12, 2021
Influence of transfusions, hemodialysis and extracorporeal life support on hyperferritinemia in critically ill patientsCornelia Knaak, Friederike S Schuster, Peter Nyvlt, et al.
Pageof 16

Showing results (121-130 of 156) with videos related to

Sort By:
Pageof 16
Annals of Hematology|April 30, 2013
Improved tolerability by a modified intermittent treatment schedule of dasatinib for patients with chronic myeloid leukemia resistant or intolerant to imatinibPaul La Rosée, Philippe Martiat, Armin Leitner, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 18, 2020
The Progressive Supranuclear Palsy Clinical Deficits ScaleInes Piot, Kerstin Schweyer, Gesine Respondek, et al.
Journal of Parkinson'S Disease|August 9, 2021
A Multisensory Deficit in the Perception of Pleasantness in Parkinson's DiseaseKathrin S Utz, Max Martini, Anne Mrochen, et al.
Haematologica|December 8, 2010
Dynamics of mutant BCR-ABL-positive clones after cessation of tyrosine kinase inhibitor therapyBenjamin Hanfstein, Martin C Müller, Sebastian Kreil, et al.
Plos One|November 28, 2013
Visual search as a tool for a quick and reliable assessment of cognitive functions in patients with multiple sclerosisKathrin S Utz, Thomas M A Hankeln, Lena Jung, et al.
Haematologica|January 29, 2008
Dynamics of BCR-ABL mutated clones prior to hematologic or cytogenetic resistance to imatinibThomas Ernst, Philipp Erben, Martin C Müller, et al.
Endocrine|March 1, 2017
Presence of headache and headache types in patients with tumors of the sellar region-can surgery solve the problem? Results of a prospective single center studySonja Siegel, Renata Weber Carneiro, Michael Buchfelder, et al.
BMC Cardiovascular Disorders|May 27, 2017
Cryoballoon vs. open irrigated radiofrequency ablation for paroxysmal atrial fibrillation: long-term FreezeAF outcomesArmin Luik, Kevin Kunzmann, Patrick Hörmann, et al.
Therapeutic Advances in Neurological Disorders|November 6, 2014
Patient preferences for disease-modifying drugs in multiple sclerosis therapy: a choice-based conjoint analysisKathrin S Utz, Jana Hoog, Andreas Wentrup, et al.
Plos One|July 12, 2021
Influence of transfusions, hemodialysis and extracorporeal life support on hyperferritinemia in critically ill patientsCornelia Knaak, Friederike S Schuster, Peter Nyvlt, et al.
Pageof 16